passa ai contenuti
Prescription drugs Anteprima di questo documento
ChiudiAnteprima di questo documento
Stiamo controllando…

Prescription drugs

Autore: Sylvia Engdahl
Editore: Detroit : Greenhaven Press/Gale Cengage Learning, ©2008.
Serie: Current controversies.
Edizione/Formato:   book_printbook : EnglishVedi tutte le edizioni e i formati
Banca dati:WorldCat
Authors debate issues on prescription drugs from the safety and effectiveness of prescription drugs to the promotion and marketing of new products to the cost of prescription medications.

(non ancora votato) 0 con commenti - Diventa il primo.

Altri come questo


Trova una copia in biblioteca

&AllPage.SpinnerRetrieving; Stiamo ricercando le biblioteche che possiedono questo documento…


Informazioni aggiuntive sul formato: Online version:
Prescription drugs.
Detroit : Greenhaven Press/Gale Cengage Learning, ©2008
Tipo materiale: Risorsa internet
Tipo documento: Book, Internet Resource
Tutti gli autori / Collaboratori: Sylvia Engdahl
ISBN: 9780737739626 0737739622 9780737739633 0737739630
Numero OCLC: 192079717
Descrizione: 246 pages ; 24 cm.
Contenuti: Is too little attention given to the safety of prescription drugs? Yes : Problems often show up after a prescription drug is on the market. Off-label prescription of drugs can lead to adverse effects / Hazel Muir --
Some prescription drugs on the market are unsafe / Consumer reports --
Prescription drugs can cause serious harm when risks are ignored / Susan Kelleher --
Post-marketing study of prescription drugs is not adequate / David J. Graham --
No : Too much caution deprives patients of prescription drugs they need. Excessive caution in drug approval causes more harm than it prevents / Scott Gottlieb --
Panic over prescription-drug risks leads people to stop taking needed medication / Irene S. Levine --
Safety concerns about prescription drugs are exaggerated and will result in higher prices / Henry I. Miller --
Lengthy approval process for prescription drugs costs lives / Gilbert L. Ross --
Terminally ill patients should be allowed to use experimental drugs / Sigrid Fry-Revere --
Do pharmaceutical companies promote unnecessary drugs? Direct-to-consumer prescription drug advertising : an overview / Carol Rados --
Yes : Many new drugs are developed merely for commercial reasons. Pharmaceutical companies define normal conditions as diseases / Ray Moynihan, Alan Cassels --
Drug promotion plays on people's fears of future illness / Barbara Mintzes --
Drug promotion has led to the overmedication of children / Anne Taylor Fleming --
No : New drugs help people who would otherwise lack effective treatment. Drugs for minor conditions are important to many people / Glenn Harlan Reynolds --
Improved prescription drugs mean better medical treatment and less illness / Alan F. Holmer --
Direct-to-consumer prescription drug advertising helps people get treatment for undiagnosed diseases / Paul Antony. Do prescription drugs in America cost too much? Rising cost of prescription drugs : an overview --
Yes : American pharmaceutical companies charge too much. Many people cannot afford the prices set by the profit-driven drug industry / Katharine Greider --
Importing less-costly prescription drugs from abroad should be allowed / Nelda Barnett --
New cancer drugs cost more than their brief extending of life may be worth / Daniel Costello --
No : pharmaceutical companies need profits to do research. High prices of drugs for minor problems pay for drugs that cure more serious ones / Peter W. Huber --
Medical innovation would stop if the government controlled drug prices / Sidney Taurel --
Controlling drug prices would reduce access to medicine / Doug Bandow --
Are dishonest or illegal prescription drug practices common? Gifts from pharmaceutical companies influence doctors / Adriane Fugh-Berman, Shahram Ahari --
Media reporting about prescription drugs is often inaccurate / Richard A. Deyo, Donald L. Patrick --
Prescription drugs are often abused / Nichole Aksamit --
Young people often trade prescription drugs with friends / Amy Harmon --
Teens use prescription drugs to get high / Donna Leinwand.
Titolo della serie: Current controversies.
Responsabilità: Sylvia Engdahl, book editor.
Maggiori informazioni:


Authors debate issues on prescription drugs from the safety and effectiveness of prescription drugs to the promotion and marketing of new products to the cost of prescription medications.


Commenti degli utenti
Recuperando commenti GoodReads…
Stiamo recuperando commenti DOGObooks


Diventa il primo.

Documenti simili

Soggetti correlati:(5)

Liste di utenti con questo documento (2)

Conferma questa richiesta

Potresti aver già richiesto questo documento. Seleziona OK se si vuole procedere comunque con questa richiesta.

Dati collegati

Primary Entity

<> # Prescription drugs
    a schema:CreativeWork, schema:Book ;
   library:oclcnum "192079717" ;
   library:placeOfPublication <> ; # Detroit
   library:placeOfPublication <> ;
   schema:about <> ; # Drugs--Public opinion
   schema:about <> ; # Pharmaceutical industry
   schema:about <> ; # Pharmaceutical policy
   schema:about <> ;
   schema:about <> ; # Drugs--Public opinion
   schema:about <> ;
   schema:about <> ; # Drug Industry
   schema:about <> ; # Drug and Narcotic Control
   schema:bookFormat bgn:PrintBook ;
   schema:contributor <> ; # Sylvia Engdahl
   schema:copyrightYear "2008" ;
   schema:datePublished "2008" ;
   schema:description "Authors debate issues on prescription drugs from the safety and effectiveness of prescription drugs to the promotion and marketing of new products to the cost of prescription medications."@en ;
   schema:exampleOfWork <> ;
   schema:inLanguage "en" ;
   schema:isPartOf <> ; # Current controversies.
   schema:isSimilarTo <> ;
   schema:name "Prescription drugs"@en ;
   schema:productID "192079717" ;
   schema:publication <> ;
   schema:publisher <> ; # Greenhaven Press/Gale Cengage Learning
   schema:url <> ;
   schema:workExample <> ;
   schema:workExample <> ;
   wdrs:describedby <> ;

Related Entities

<> # Greenhaven Press/Gale Cengage Learning
    a bgn:Agent ;
   schema:name "Greenhaven Press/Gale Cengage Learning" ;

<> # Current controversies.
    a bgn:PublicationSeries ;
   schema:hasPart <> ; # Prescription drugs
   schema:name "Current controversies." ;
   schema:name "Current controversies" ;

<> # Drug and Narcotic Control
    a schema:Intangible ;
   schema:name "Drug and Narcotic Control"@en ;

<> # Pharmaceutical industry
    a schema:Intangible ;
   schema:name "Pharmaceutical industry"@en ;

<> # Pharmaceutical policy
    a schema:Intangible ;
   schema:name "Pharmaceutical policy"@en ;

<> # Drugs--Public opinion
    a schema:Intangible ;
   schema:name "Drugs--Public opinion"@en ;

<> # Sylvia Engdahl
    a schema:Person ;
   schema:familyName "Engdahl" ;
   schema:givenName "Sylvia" ;
   schema:name "Sylvia Engdahl" ;

    a schema:ProductModel ;
   schema:isbn "0737739622" ;
   schema:isbn "9780737739626" ;

    a schema:ProductModel ;
   schema:isbn "0737739630" ;
   schema:isbn "9780737739633" ;

    a schema:CreativeWork ;
   rdfs:label "Prescription drugs." ;
   schema:description "Online version:" ;
   schema:isSimilarTo <> ; # Prescription drugs

Content-negotiable representations

Chiudi finestra

Per favore entra in WorldCat 

Non hai un account? Puoi facilmente crearne uno gratuito.